The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
117462164 11746216 4 F 20151102 20160805 20151117 20160816 EXP PHHO2015ZA018880 SANDOZ 59.53 YR F Y 85.00000 KG 20160816 MD ZA ZA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
117462164 11746216 1 PS METFORMIN METFORMIN HYDROCHLORIDE 1 Oral 850 MG, BID 75985 850 MG BID
117462164 11746216 2 SS ENALAPRIL ENALAPRIL 1 Oral 10 MG, BID 0 10 MG BID
117462164 11746216 3 SS AMLODIPINE AMLODIPINE BESYLATE 1 Oral 5 MG, QD 0 5 MG QD
117462164 11746216 4 SS LASIX FUROSEMIDE 1 Unknown 0
117462164 11746216 5 SS BLINDED NO TREATMENT RECEIVED INVESTIGATIONAL PRODUCT 1 Intravenous (not otherwise specified) CODE NOT BROKEN 0
117462164 11746216 6 SS BLINDED PLACEBO INVESTIGATIONAL PRODUCT 1 Intravenous (not otherwise specified) CODE NOT BROKEN 0
117462164 11746216 7 SS BLINDED RLX030 SERELAXIN 1 Intravenous (not otherwise specified) CODE NOT BROKEN 0
117462164 11746216 8 C INSULIN INSULIN NOS 1 Unknown 4 U, UNK 0 4 DF
117462164 11746216 9 C CLEXANE ENOXAPARIN SODIUM 1 Subcutaneous 40 MG, QD Y 0 40 MG QD
117462164 11746216 10 C CLEXANE ENOXAPARIN SODIUM 1 Subcutaneous 20 MG, UNK Y 0 20 MG
117462164 11746216 11 C FUROSEMIDE. FUROSEMIDE 1 Oral 80 MG, BID U 0 80 MG BID
117462164 11746216 12 C ENALAPRIL ENALAPRIL 1 Oral 10 MG, BID U 0 10 MG BID
117462164 11746216 13 C CARLOC CARVEDILOL 1 Oral 6.25 MG, BID U 0 6.25 MG BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
117462164 11746216 1 Diabetes mellitus
117462164 11746216 2 Product used for unknown indication
117462164 11746216 3 Product used for unknown indication
117462164 11746216 4 Product used for unknown indication
117462164 11746216 5 Cardiac failure acute
117462164 11746216 6 Cardiac failure acute
117462164 11746216 7 Cardiac failure acute
117462164 11746216 8 Diabetes mellitus
117462164 11746216 9 Prophylaxis
117462164 11746216 11 Product used for unknown indication
117462164 11746216 12 Product used for unknown indication
117462164 11746216 13 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
117462164 11746216 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
117462164 11746216 Acute kidney injury
117462164 11746216 Hypotension
117462164 11746216 Liver injury
117462164 11746216 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
117462164 11746216 1 20150818 0
117462164 11746216 2 20151101 0
117462164 11746216 3 20151101 0
117462164 11746216 4 20151101 0
117462164 11746216 5 20151029 20151031 0
117462164 11746216 6 20151029 20151031 0
117462164 11746216 7 20151029 20151031 0
117462164 11746216 8 20151103 0
117462164 11746216 9 20151029 0
117462164 11746216 10 20151102 0